American Healthcare REIT (AHR) director receives 2,594 restricted stock shares
Rhea-AI Filing Summary
O'Quinn Marvin R reported acquisition or exercise transactions in this Form 4 filing.
American Healthcare REIT, Inc. director Marvin R. O'Quinn received an equity grant of company stock. He was granted 2,594 shares of restricted common stock on June 24, 2026, in connection with his re-election to the board. These restricted shares vest in full on June 24, 2027. Following this award, he directly holds 20,656 shares of common stock. The grant was a compensation-related award at no cash cost to him, rather than an open-market purchase.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 2,594 shares
Net Buy
1 txn
Insider
O'Quinn Marvin R
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 2,594 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 20,656 shares (Direct)
Footnotes (1)
- F1. Upon his re-election as a director to the board of directors of the Issuer on June 24, 2026, the Reporting Person was granted 2,594 shares of restricted common stock on June 24, 2026. The reported shares of restricted common stock vest on June 24, 2027.
Key Figures
Restricted stock grant: 2,594 shares
Post-transaction holdings: 20,656 shares
Grant price per share: $0.00 per share
+1 more
4 metrics
Restricted stock grant
2,594 shares
Restricted common stock granted June 24, 2026
Post-transaction holdings
20,656 shares
Total common stock directly held after grant
Grant price per share
$0.00 per share
Reported transaction price for restricted stock grant
Vesting date
June 24, 2027
Vesting date for 2,594 restricted shares
Key Terms
restricted common stock, vest, Grant, award, or other acquisition
3 terms
restricted common stock financial
"the Reporting Person was granted 2,594 shares of restricted common stock"
Restricted common stock is company shares that carry limits on selling or transferring for a set period or until certain conditions are met, like time-based vesting or regulatory clearance. Think of them as shares in a locked box that gradually open; they can become freely tradable later but initially reduce the number of shares available on the market. Investors watch restricted stock because its eventual release can change a company’s share supply, affect stock price, and influence control and dilution.
vest financial
"The reported shares of restricted common stock vest on June 24, 2027."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
Grant, award, or other acquisition financial
"transaction code description: Grant, award, or other acquisition"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did American Healthcare REIT (AHR) report for Marvin R. O'Quinn?
American Healthcare REIT reported that director Marvin R. O'Quinn received a grant of 2,594 shares of restricted common stock. The award was given on June 24, 2026, as part of his compensation upon re-election to the board of directors.
Was cash paid for the restricted stock granted to Marvin R. O'Quinn at AHR?
No cash changed hands for this grant; the reported transaction price per share is $0.00. The 2,594 restricted shares represent a non-cash equity compensation award given to Marvin R. O'Quinn upon his re-election to American Healthcare REIT’s board.
Is Marvin R. O'Quinn’s AHR Form 4 transaction an open-market buy or a compensation grant?
The filing describes the transaction as a compensation grant, not an open-market buy. The Form 4 uses code “A” for grant, award, or other acquisition and reports a zero purchase price for the 2,594 restricted common shares.